Evidence map›Paper›PMID 24050945›Full record

ArticleVascular pharmacology

Interactions of PPAR-alpha and adenosine receptors in hypoxia-induced angiogenesis.

Yasmeen Q Rizvi, Chander S Mehta, Adebayo Oyekan

Open access · greenAbstract read
In one paragraph

Article in Vascular pharmacology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Cortical Thickness of Native Tibetans in the Qinghai-Tibetan Plateau.AJNR. American journal of neuroradiology · 2017
    Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Yasmeen Q RizviCenter for Cardiovascular Diseases, College of Pharmacy and Health Sciences, Texas Southern University, Houston, TX 77004, USA. Electronic address: yas0464@yahoo.com.
Chander S Mehta
Adebayo Oyekan
Texas Southern University · US

Funding

TEXAS SOUTHERN UNIVERSITY RESEARCH SCIENTIST AWARDUH1HL003674 · NHLBI · TEXAS SOUTHERN UNIVERSITY · PI OYEKAN, ADEBAYO O. · 1996 to 2004
$2.5M
TEXAS SOUTHERN UNIVERSITY RESEARCH SCIENTIST AWARDR25HL003674 · NHLBI · TEXAS SOUTHERN UNIVERSITY · PI OYEKAN, ADEBAYO O. · 2006 to 2010
$2.0M
NHLBI NIH HHS HL03674NHLBI NIH HHS R25 HL003674NHLBI NIH HHS UH1 HL003674
6 · The paper itself

Abstract

Hypoxia and adenosine are known to upregulate angiogenesis; however, the role of peroxisome proliferator-activated receptor alpha (PPARα) in angiogenesis is controversial. Using transgenic Tg(fli-1:EGFP) zebrafish embryos, interactions of PPARα and adenosine receptors in angiogenesis were evaluated under hypoxic conditions. Epifluorescent microscopy was used to assess angiogenesis by counting the number of intersegmental (ISV) and dorsal longitudinal anastomotic vessel (DLAV) at 28 h post-fertilization (hpf). Hypoxia (6h) stimulated angiogenesis as the number of ISV and DLAV increased by 18-fold (p<0.01) and 100 ± 8% (p<0.001), respectively, at 28 hpf. Under normoxic and hypoxic conditions, WY-14643 (10 μM), a PPARα activator, stimulated angiogenesis at 28 hpf, while MK-886 (0.5 μM), an antagonist of PPARα, attenuated these effects. Compared to normoxic condition, adenosine receptor activation with NECA (10 μM) promoted angiogenesis more effectively under hypoxic conditions. Involvement of A2B receptor was implied in hypoxia-induced angiogenesis as MRS-1706 (10nM), a selective A2B antagonist attenuated NECA (10 μM)-induced angiogenesis. NECA- or WY-14643-induced angiogenesis was also inhibited by miconazole (0.1 μM), an inhibitor of epoxygenase dependent production of eicosatrienoic acid (EET) epoxide. Thus, we conclude that: activation of PPARα promoted angiogenesis just as activation of A2B receptors through an epoxide dependent mechanism.

Indexed as

Adenosine-5'-(N-ethylcarboxamide)AnimalsChlorobenzenesFatty Acids, MonounsaturatedFemaleHypoxiaIndolesMaleMiconazoleMicroscopy, FluorescenceNeovascularization, PhysiologicPPAR alphaPurinesPyrimidinesReceptor, Adenosine A2BReceptors, Purinergic P1Adenosine-5'-(N-ethylcarboxamide)Chlorobenzeneseicosenoic acidFatty Acids, MonounsaturatedIndolesMiconazoleMK-886N-(4-acetylphenyl)-2-(4-(2,3,6,7-tetrahydro-2,6-dioxo-1,3-dipropyl-1H-purin-8-yl)phenoxy)acetamidepirinixic acidPPAR alphaPurinesPyrimidinesReceptor, Adenosine A2BReceptors, Purinergic P15′-N-ethylcarboxamidoadenosineAdenosine receptorsAngiogenesisCYP2C9cytochrome P450 2C9DLAVdorsal longitudinal anastomotic vesselEETeicosatrienoic acidEicosatrienoic acidHIF-1αhour post-fertilizationhpfhypoxia-inducible factor-1 alphaIL-8interleukin-8intersegmental vesselISVNECAperoxisome proliferator-activated receptor alphaperoxisome proliferator-activated receptor gammaPGARPPARαPPARγPPARγ angiopoietin-related geneTg(fli-1:EGFP)thrombospondin-1transgenic friendly leukemia integration-1 enhanced green fluorescent proteinTSP-1Zebrafish

Identifiers

PMID24050945
PMCPMC3876467
OpenAlexW2046245112

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.